Curaleaf Holdings, Inc. (CURLF) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.07 per share a year ago.
There's a lot of concern in the markets these days with how tariffs will affect growth stocks like Nvidia and Apple and whether they drag down their earnings.
The U.S. cannabis market continues to expand rapidly, with expected revenues reaching over $45 billion by 2025. This growth is fueled by rising consumer demand and ongoing state-level legalization. So far, 24 states and Washington, D.C. have legalized adult-use marijuana. Nearly 80% of Americans now live near a dispensary. Although federal reform has faced challenges, momentum continues to build. Most recently, a major legalization proposal in Florida failed to meet the required 60% threshold. However, efforts remain active across other key states. Many investors are now focused on the DEA's expected rescheduling of cannabis. This move could reduce tax burdens and increase medical research. With this news circulating, top marijuana stocks are showing renewed volatility and opportunity this week.
With the tariffs in place, will marijuana stocks continue to stay on the floor? Or is this the time to get active in response to the market as a whole being down? At this time, there are several paths to choose from, all having an unpredictable outcome. The reason for the unknowns is that no one knows what these new tariffs will bring exactly. So people are using the knowledge and principles they know to make better investments.
Those invested in cannabis stocks understand that taking profits has been a struggle. There is a hefty level of volatile trading that has kept the sector on a downward trend. This trend is what makes any sector, including cannabis nearly impossible to be profitable. At one time marijuana stocks showed healthy trading even in a down trend. Over the last few years, the trading behavior of public cannabis companies has changed drastically.
Curaleaf Holdings recently reported in-line financial results for Q4-2024 and FY2024. The company saw expansion in its revenue from international sales but contraction domestically. Revenue growth for FY2024 was flat compared to FY2023.
Marijuana stock investors are on edge with all this uncertainty surrounding the industry. With Donald Trump as our new president, there has been fear of what may become of the legal cannabis industry. Many feel that this will impact not only how marijuana stocks perform but also the small craft legal operators. At this time, there is a split between corporate cannabis-like MSOs such as Truleive versus small-batch farmers. For the small-batch legal operators, it has been tough to deal with the increase in taxes and regulatory concerns that make operating the business more challenging.
Curaleaf Holdings, Inc. (OTCPK:CURLF) Q4 2024 Earnings Conference Call March 1, 2025 5:00 PM ET Company Participants Camilo Lyon - Chief Investment Officer Boris Jordan - Chairman and Chief Executive Officer Ed Kremer - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Russell Stanley - Beacon Securities Matt Bottomley - Canaccord Genuity Bill Kirk - ROTH Capital Partners Eric Des Lauriers - Craig-Hallam Capital Group Pablo Zuanic - Zuanic & Associates Operator Good day and welcome to the Curaleaf Holdings Fourth Quarter and Fiscal Year End 2024 Earnings Conference Call. All participants will be in a listen-only mode.
Curaleaf Holdings, Inc. (CURLF) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.01 per share a year ago.
Trulieve Cannabis Corp. on Wednesday became the third large U.S. cannabis company to launch a line of beverages containing the intoxicant THC, as efforts to legalize cannabis on the federal level remain in limbo.
Marijuana stock investors have a strong outlook towards the future of the industry. What this means is with all the concerns about what will take place this year investors see the future being more profitable. The reason is based on the politics and regulatory fears with Donald Trump now in office. Many legal operators in the United States are all trying to stay productive and under the radar.
Curaleaf's stock price has dropped in the past few years as the cannabis industry's momentum and enthusiasm have waned. The CURLF share price is hovering near its all-time low, meaning that its market cap has dropped to $1.1 billion, down from a record high of $12.2 billion.